Hygiene in der Dermatologie – Teil 2: Kommensalen und Infektionserreger, antimikrobielle Behandlung, Hygieneaspekte ausgewählter Infektionskrankheiten

Zusammenfassung

In diesem Beitrag werden Kommensalen und relevante Infektionserreger des dermatologischen Patienten wie auch seiner Umgebung systematisch dargestellt und im Hinblick auf die krankenhaushygienische Bedeutung eingeordnet. Auf der antimikrobiellen Behandlung sowie Hygiene-Maßnahmen ausgewählter dermatologischer Erkrankungen liegt ein weiterer Fokus.

Abstract

Commensals and pathogenic agents of dermatological patients as well as its environment are presented systematically and with respect to their hygiene relevance. A further focus is on antimicrobial treatment and hygiene aspects of selected dermatological diseases.

Schlüsselwörter

Kommensalen - Infektionserreger - antimikrobielle Therapie - Hygieneaspekte ausgewählter dermatologischer Erkrankungen

Keywords

Commensals - pathogenic bacteria - antimicrobial treatment - hygiene aspects of selected dermatological diseases

• Literatur

• 1 Ulmer M, Lademann J, Patzelt A. et al. New strategies for preoperative skin antisepsis. Skin Pharmacol Physiol 2014; 27: 283-292
• 2 Dumville JC, McFarlane E, Edwards P. et al. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 2013; 3: CD003949
• 3 Stingeni L, Lapomarda V, Lisi P. Occupational hand dermatitis in hospital environments. Contact Derm 1995; 33: 172-176
• 4 Fritz SA, Hogan PG, Camins BC. et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013; 57: 559-568
• 5 Ho CM, Li CY, Ho MW. et al. High rate of qacA and qacB positive methicillin resistant Staphylococcus aureus isolates from chlorhexidine impregnated catheter related bloodstream infections. Antimicrob Agents Chemother 2012; 56: 5693-5697
• 6 McNeil JC, Hulten KG, Kaplan SL. et al. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. J Pediatr Infect Dis J 2013; 32: 124-128
• 7 McNeil JC, Ligon JA, Hulten KG. et al. Staphylococcus aureus infections in children with congenital heart disease. J Pediatric Infect Dis Soc 2013; 2: 337-344
• 8 Al-Doori Z, Goroncy-Bermes P, Gemmell CG. et al. Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 2007; 59: 1280-1281
• 9 Hübner NO, Siebert J, Kramer A. Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds. Skin Pharmacol Physiol 2010; 23: 244-258
• 10 Desinfektionsmittel-Liste des VAH. Wiesbaden: mhp-Verlag; 2021